Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Journal of Translational Medicine
|
February 14, 2013
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
Antonio Daponte, Simona Signoriello, Luigi Maiorino, et al.
Oncotarget
|
September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patients
Lucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Marina Fabbi, Delfina Costa, Daniela Russo, et al.
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
The International Journal of Biological Markers
|
November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial
Stefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Journal of Translational Medicine
|
February 14, 2013
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
Antonio Daponte, Simona Signoriello, Luigi Maiorino, et al.
Oncotarget
|
September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib <i>versus</i> chemotherapy in advanced non-small cell lung cancer patients
Lucia Kim, Mauro Saieg, Massimo Di Maio, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
Marina Fabbi, Delfina Costa, Daniela Russo, et al.
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
Plos One
|
August 6, 2010
Time spent for activation of non-profit studies in oncology in Italy
Gianfranco De Feo, Simona Signoriello, Jane C Bryce, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2011
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial
Cesare Gridelli, Ciro Gallo, Alessandro Morabito, et al.
Endocrine
|
March 24, 2018
Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study
Maria Grazia Chiofalo, Simona Signoriello, Franco Fulciniti, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
The International Journal of Biological Markers
|
November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial
Stefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.
Page
of 6